Antimycoplasma drugs paved the way for the treatment of mycoplasma infections even before the vaccines were developed. Macrolides, tetracyclines, or aminoglycosides were being used for long, incorporating quinolones in the newer regimes. Former drug classes target protein synthesis, whereas the latter one targets DNA synthesis. These drugs proved quite effective and helped minimize severity and loss to farmers. However, prolonged use of antibiotics may have serious concerns of drug resistance, side effects, and drug residues in food animal products. In addition, despite treating mycoplasma infection, some drugs create a carrier state of infection that can spread the infection without being recognized. Hence, novel alternate therapeutics need to be explored to overcome these limitations whilst checking the antibiotic resistance with regular antibiotic sensitivity tests, which need to be standardized for different mycoplasma. Future therapeutics are needed under the prevailing situations of emerging and transboundary spread of mycoplasma infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.